Mark Blaufuss
Known title: DirectorCIK: 0001625944
Associated companies
Transaction History
| BLBD | ▲ Buy | Grant | 2,297 | $0 | 4/1/2026 | View on chart |
| BLBD | ▲ Buy | Grant | 4,099 | $0 | 4/1/2025 | View on chart |
| BLBD | ▲ Buy | Grant | 1,954 | $0 | 4/1/2024 | View on chart |
| BLBD | ▲ Buy | Grant | 1,984 | $0 | 6/1/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Blue Bird Lays Out Stock Market Strategy, Analysts Optimistic
Blue Bird Laps the Stock Market with a new strategy, drawing analyst optimism. The company partnered with LightSource to centralize supply‑chain data, cutting sourcing decision time by two days. With a trailing P/E of 6.4 and a target range of $82‑$95, the stock sits near its 52‑week low but could benefit from the operational efficiencies.
Blue Bird Lays Out Stock Market Strategy, Analysts Optimistic. Blue Bird Laps the Stock Market with a new strategy, drawing analyst optimism. The company partnered with LightSource to centralize supply‑chain data, cutting sourcing decision time by two days. With a trailing P/E of 6.4 and a target range of $82‑$95, the stock sits near its 52‑week low but could benefit from the operational efficiencies.